HLS Therapeutics Inc.
HLS.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.72M | 10.78M | 12.15M | 17.73M | 17.46M |
| Total Receivables | 7.86M | 8.22M | 9.05M | 7.80M | 7.53M |
| Inventory | 8.14M | 7.11M | 6.82M | 7.48M | 9.06M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.37M | 1.39M | 2.01M | 1.05M | 1.36M |
| Total Current Assets | 29.09M | 27.49M | 30.04M | 34.07M | 35.40M |
|
|
|||||
| Total Current Assets | 29.09M | 27.49M | 30.04M | 34.07M | 35.40M |
| Net Property, Plant & Equipment | 1.34M | 1.27M | 1.05M | 972.00K | 997.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 105.63M | 109.68M | 116.05M | 117.18M | 122.12M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.47M | 1.79M | 1.94M | 1.73M | 1.39M |
| Total Assets | 137.53M | 140.23M | 149.07M | 153.95M | 159.90M |
|
|
|||||
| Total Accounts Payable | 10.44M | 10.59M | 8.34M | 8.68M | 8.71M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.82M | 4.75M | 6.15M | 5.69M | 5.28M |
| Total Finance Division Other Current Liabilities | 10.87M | 8.12M | 13.10M | 9.47M | 8.55M |
| Total Other Current Liabilities | 10.87M | 8.12M | 13.10M | 9.47M | 8.55M |
| Total Current Liabilities | 26.12M | 23.46M | 27.59M | 23.84M | 22.55M |
|
|
|||||
| Total Current Liabilities | 26.12M | 23.46M | 27.59M | 23.84M | 22.55M |
| Long-Term Debt | 44.45M | 48.83M | 48.97M | 57.63M | 60.74M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 552.00K | 502.00K | 457.00K | 417.00K | 426.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.73M | 5.70M | 5.50M | 5.26M | 4.85M |
| Total Liabilities | 75.86M | 78.49M | 82.51M | 87.15M | 88.56M |
|
|
|||||
| Common Stock & APIC | 272.50M | 272.26M | 272.85M | 275.03M | 275.73M |
| Retained Earnings | -204.15M | -202.82M | -199.83M | -198.33M | -194.18M |
| Treasury Stock & Other | -6.68M | -7.70M | -6.46M | -9.90M | -10.21M |
| Total Common Equity | 61.67M | 61.74M | 66.56M | 66.80M | 71.34M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 61.67M | 61.74M | 66.56M | 66.80M | 71.34M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 61.67M | 61.74M | 66.56M | 66.80M | 71.34M |
|
|
|||||